Position in LQDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$277,380
-$14,379,967 QoQ
Shares Held
3,479
-99.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#244
of 334 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Dec 31, 2023CallValue
$226,164
CallShares
18,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pale Fire Capital SE holds $4,466,326 across 3 Drug Manufacturers - Specialty & Generic names. LQDA ranks #3 (6.2% of the industry book) .
All Filings in LQDA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,380 | 3,479 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,657,347 | 388,377 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $13,085,230 | 379,392 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,473,995 | 240,721 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,067,822 | 85,700 | Shares | Defined | 2025-08-13 | |
| 2023-12-31 | $226,164 | 18,800 | Call | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||